Alerts will be sent to your verified email
Verify Email
BAFNAPH
|
Bafna Pharma
|
Coral Laboratories
|
Alpa Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-52.11 % | 6.99 % | 8.11 % |
|
5yr average Equity Multiplier
|
3.77 | 1.2 | 1.24 |
|
5yr Average Asset Turnover Ratio
|
0.42 | 0.47 | 0.66 |
|
5yr Avg Net Profit Margin
|
-36.55 % | 12.64 % | 10.22 % |
|
Price to Book
|
3.95 | 1.02 | 1.2 |
|
P/E
|
48.7 | 8.5 | 10.55 |
|
5yr Avg Cash Conversion Cycle
|
0.18 Days | 26.14 Days | 119.67 Days |
|
Inventory Days
|
87.65 Days | 79.65 Days | 52.46 Days |
|
Days Receivable
|
132.64 Days | 112.59 Days | 147.5 Days |
|
Days Payable
|
210.48 Days | 147.17 Days | 97.89 Days |
|
5yr Average Interest Coverage Ratio
|
-5.68 | 114.88 | 75.25 |
|
5yr Avg ROCE
|
-11.61 % | 8.79 % | 10.84 % |
|
5yr Avg Operating Profit Margin
|
-21.98 % | 11.85 % | 7.49 % |
|
5 yr average Debt to Equity
|
1.41 | 0.03 | 0.02 |
|
5yr CAGR Net Profit
|
12.0 % | 17.24 % | 55.43 % |
|
5yr Average Return on Assets
|
-16.11 % | 5.83 % | 6.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.0 % | 71.51 % | 57.29 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-15.12 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bafna Pharma
|
Coral Laboratories
|
Alpa Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|